ERELEL, M. Et Al. 2021. Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. PHARMACEUTICS , vol.13, no.11 .

ERELEL, M., KAŞKAL, M., Akbal-Dagistan, O., İŞSEVER, H., DAĞISTANLI, A. S., BALKANCI, H., ... OĞUZ, M. S.(2021). Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial. PHARMACEUTICS , vol.13, no.11.

ERELEL, Mustafa Et Al. "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial," PHARMACEUTICS , vol.13, no.11, 2021

ERELEL, Mustafa Et Al. "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial." PHARMACEUTICS , vol.13, no.11, 2021

ERELEL, M. Et Al. (2021) . "Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial." PHARMACEUTICS , vol.13, no.11.

@article{article, author={Mustafa ERELEL Et Al. }, title={Early Effects of Low Molecular Weight Heparin Therapy with Soft-Mist Inhaler for COVID-19-Induced Hypoxemia: A Phase IIb Trial}, journal={PHARMACEUTICS}, year=2021}